Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gemma Pujol

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Crohn'S & Colitis 360|March 24, 2026
Fatigue in pediatric patients with inflammatory bowel disease: a multicenter study by the SEGHNPRafael Martin-Masot, Marta Velasco Rodríguez-Belvís, Gemma Pujol Muncunill, et al.
Anales De Pediatria|April 25, 2017
[A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for pediatric Crohn's disease]Víctor Manuel Navas-López, Gemma Pujol Muncunill, Enrique Llerena, et al.
BMC Gastroenterology|June 29, 2023
Efficacy of Crohn's disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart reviewMaría Clara Jijón Andrade, Gemma Pujol Muncunill, Ana Lozano Ruf, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 29, 2024
Impact of pediatric inflammatory bowel disease on caregivers' work productivity: A multicenter study by the SEGHNPMarta Velasco Rodríguez-Belvís, Laura Palomino, Gemma Pujol Muncunill, et al.
Nutricion Hospitalaria|December 27, 2019
[Assessing the implementation of a nutritional screening protocol in patients admitted to the Medicine Department of a local hospital]M ª Asuncion Recasens Gracia, Cèlia Puig Cepero, Gabriel Giménez-Pérez, et al.
The Journal of Trauma and Acute Care Surgery|March 31, 2022
Dynamic use of fibrinogen under viscoelastic assessment results in reduced need for plasma and diminished overall transfusion requirements in severe traumaMarta Barquero López, Javier Martínez Cabañero, Alejandro Muñoz Valencia, et al.
Alimentary Pharmacology & Therapeutics|June 23, 2022
Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real-world patient mixOhad Atia, Gemma Pujol-Muncunill, Víctor Manuel Navas-López, et al.
European Journal of Pediatrics|June 15, 2024
Correction to: Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNPMarta Velasco Rodríguez-Belvís, Laura Palomino, Gemma Pujol-Muncunill, et al.
European Journal of Pediatrics|May 21, 2024
Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNPMarta Velasco Rodríguez-Belvís, Laura Palomino, Gemma Pujol-Muncunill, et al.
Paediatric Drugs|May 23, 2024
Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHANShlomi Cohen, Helena Rolandsdotter, Kaija-Leena Kolho, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Crohn'S & Colitis 360|March 24, 2026
Fatigue in pediatric patients with inflammatory bowel disease: a multicenter study by the SEGHNPRafael Martin-Masot, Marta Velasco Rodríguez-Belvís, Gemma Pujol Muncunill, et al.
Anales De Pediatria|April 25, 2017
[A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for pediatric Crohn's disease]Víctor Manuel Navas-López, Gemma Pujol Muncunill, Enrique Llerena, et al.
BMC Gastroenterology|June 29, 2023
Efficacy of Crohn's disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart reviewMaría Clara Jijón Andrade, Gemma Pujol Muncunill, Ana Lozano Ruf, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 29, 2024
Impact of pediatric inflammatory bowel disease on caregivers' work productivity: A multicenter study by the SEGHNPMarta Velasco Rodríguez-Belvís, Laura Palomino, Gemma Pujol Muncunill, et al.
Nutricion Hospitalaria|December 27, 2019
[Assessing the implementation of a nutritional screening protocol in patients admitted to the Medicine Department of a local hospital]M ª Asuncion Recasens Gracia, Cèlia Puig Cepero, Gabriel Giménez-Pérez, et al.
The Journal of Trauma and Acute Care Surgery|March 31, 2022
Dynamic use of fibrinogen under viscoelastic assessment results in reduced need for plasma and diminished overall transfusion requirements in severe traumaMarta Barquero López, Javier Martínez Cabañero, Alejandro Muñoz Valencia, et al.
Alimentary Pharmacology & Therapeutics|June 23, 2022
Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real-world patient mixOhad Atia, Gemma Pujol-Muncunill, Víctor Manuel Navas-López, et al.
European Journal of Pediatrics|June 15, 2024
Correction to: Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNPMarta Velasco Rodríguez-Belvís, Laura Palomino, Gemma Pujol-Muncunill, et al.
European Journal of Pediatrics|May 21, 2024
Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNPMarta Velasco Rodríguez-Belvís, Laura Palomino, Gemma Pujol-Muncunill, et al.
Paediatric Drugs|May 23, 2024
Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHANShlomi Cohen, Helena Rolandsdotter, Kaija-Leena Kolho, et al.
Pageof 5